RTP gene therapy company Opus Genetics appoints CEO
Research Triangle-based gene therapy company Opus Genetics is appointing its acting CEO to the permanent role, the company announced this week.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed